Search > Alzheimer's Disease
325 Participants NeededMy employer runs this trial

ALZ-801 for Alzheimer's Disease

(APOLLOE4 Trial)

Recruiting at 7 trial locations
Age: 18+
Sex: Any
Trial Phase: Phase 3
Sponsor: Alzheon Inc.

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. This is a double-blind, randomized trial with one dose of ALZ-801 compared to placebo.

Are You a Good Fit for This Trial?

This trial is for people with early Alzheimer's disease who have two copies of the APOE4 gene. They should show memory loss over the past year and have specific scores on cognitive tests like MMSE and CDR. People can't join if they've had recent strokes, seizures (except childhood febrile seizures), other brain disorders, major depression in the last year, or are taking certain dementia medications.

Inclusion Criteria

Do you have a family member, friend, or caregiver who spends at least 8 hours per week with you and would be willing to participate in the study alongside you?
Have you been formally diagnosed with Alzheimer's Disease?
Over the past year, have you or someone close to you noticed that your memory seems worse than before?
See 3 more

Exclusion Criteria

Do you have any other serious medical conditions that could make it more dangerous for you to participate in a trial?

Timeline

Screening

Participants are evaluated to confirm eligibility

Up to 4 weeks

Treatment

Participants receive the study treatment

14 weeks
Includes regular clinic visits and assessments

Follow-up

Participants are monitored for safety

4 weeks

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.